Melinta Therapeutics Publishes Complete Results from Phase III TANGO 2 Study of Vabomere™ (meropenem and vaborbactam)

World News: . []

NEW HAVEN Conn Oct 02 2018 GLOBE NEWSWIRE -- Melinta Therapeutics Inc. (NASDAQ: MLNT a commercial-stage company discovering developing and commercializing novel antibiotics to treat serious bacterial infections today announced that r esults ...

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 13:00 GMT Tuesday 2nd October 2018

Published: .

Search for other references to "melinta" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us